Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region-Reference-Cited by-同舟云学术

Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region

Published:2010-06-21 Issue:12 Volume:50 Page:2695-2706
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:

Author:

Stolz Martin,Tinguely Caroline,Graziani Mauro,Fontana Stefano,Gowland Peter,Buser Andreas,Michel Martine,Canellini Giorgia,Züger Max,Schumacher Philippe,Lelie Nico,Niederhauser Christoph

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2010.02732.x/fullpdf

Reference40 articles.

1. Niederhauser C Weingand T Candotti D Maier A Tinguely C Wuillemin WA Gowland P Allain WP Stolz M Fatal outcome of a hepatitis B virus (HBV) transmission-transmitted infection Vox Sang 2010 98 504 7

2. Infectivity of blood components with lower hepatitis B virus DNA levels identified in a lookback program;Satake;Transfusion,2007

3. HBsAg non-reactive HBV infection in blood donors: transmission and pathogenicity;Gerlich;J Med Virol,2007

4. Feasibility and usefulness of an efficient anti-HBc screening programme in blood donors;Allain;Transfus Med,1995

5. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion;Allain;Br J Haematol,1999

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields from a single blood center in China with 10-years review;BMC Infectious Diseases;2022-03-23

2. Prevalence of Occult Hepatitis B Virus Infection in Blood Donors with Negative ID-NAT in Switzerland;Transfusion Medicine and Hemotherapy;2022

3. Excluding Occult Hepatitis B Infection before Assigning False-Positive Status to Non-Repeatable NAT Reactivity: Concerning Stolz et al. “Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country” [Transfus Med Hemother. 2019 Apr;46(2):104–10];Transfusion Medicine and Hemotherapy;2019-08-29

4. Current Knowledge of Occult Hepatitis B Infection and Clinical Implications;Seminars in Liver Disease;2019-03-25

5. Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country;Transfusion Medicine and Hemotherapy;2019